Eli Lilly - 2/23

Entry	Author	Date	Location
Bydureon FDA Deadline Set	Luke Timmerman	08/10/11	San Diego
Amylin & Takeda Halt Obesity Drug Development	Bruce V. Bigelow	08/04/11	San Diego
Vertex Sales Much Bigger Than Expected, Amylin Re-Submits Exenatide, Mini VC Fund Debuts, & More San Diego Life Sciences News	Bruce V. Bigelow	08/04/11	San Diego
Stéphane Bancel, Former bioMérieux CEO, Talks Future of Startups, Diagnostics, Pharma	Gregory T. Huang	08/04/11	Boston
Biogen Gets Euro Approval, BSX Shows Solid Q2, Alkermes Tries Again, & More Boston-Area Life Sciences News	Erin Kutz	07/29/11	Boston
Bydureon Sent Back to FDA	Luke Timmerman	07/28/11	San Diego
Trius and Bayer Sign Deal, Brooks Buys Nexus Biosystems, Wildcat Discovery Gets $7.5M Financing, & More San Diego Life Sciences News	Bruce V. Bigelow	07/28/11	San Diego
EnVivo, Backed by Fidelity Biosciences, Tests New Weapon Against Alzheimer’s	Arlene Weintraub	07/25/11	Boston
Amylin, Alkermes Once-Weekly Diabetes Drug Passes Heart Trial Demanded by FDA	Luke Timmerman	07/07/11	San Diego
Alkermes Wins Over Investors With Plan To Become Trans-Atlantic “Big Biotech”	Luke Timmerman	07/06/11	Boston
Lilly to Hire 20 in San Diego	Bruce V. Bigelow	06/28/11	San Diego
Inception 1 Raises $5M, VCs Pessimistic About U.S. Biotech Funding, EU Approves Amylin’s Once-a-Week Diabetes Drug, & More San Diego Life Sciences News	Bruce V. Bigelow	06/23/11	San Diego
Amylin, Alkermes Diabetes Med OKd in EU	Luke Timmerman	06/21/11	San Diego
PureTech Ventures Launches Tal Medical To Develop Magnetic-Field Treatment for Depression	Arlene Weintraub	06/13/11	Boston
Orexigen Halts U.S. Work on Weight Loss Drug, Illumina Cuts Price for Sequencing Patient Genomes, Ambit Pulls IPO, & More San Diego Life Sciences News	Bruce V. Bigelow	06/09/11	San Diego
FDA Approves Optimer Antibiotic, Amylin Wins Legal Round Against Lilly, Investors Excited by Orexigen Move, & More San Diego Life Sciences News	Bruce V. Bigelow	06/02/11	San Diego
Amylin Gets TRO Against Lilly	Bruce V. Bigelow	05/26/11	San Diego
How to Make Money in Biotech With No Hope of Going Public, Slim Odds of Getting Acquired	Luke Timmerman	05/23/11	National
Shire Pays $750M for Advanced BioHealing, Amylin Sues Lilly, Pacira CEO Describes His Most Difficult Task, & More San Diego Life Sciences News	Bruce V. Bigelow	05/19/11	San Diego
Resolve Nabs $2M For Lupus Drug, First Step on the Road to Returns With No IPO, No M&A	Luke Timmerman	05/17/11	Seattle
Amylin Sues Eli Lilly, Arguing Breach of Contract in Marketing Rival Diabetes Drug	Luke Timmerman	05/16/11	San Diego
Alkermes Acquires Elan Drug Manufacturing Unit for $960M	Luke Timmerman	05/09/11	Boston
West Wireless Repositions Itself as an Impartial Arbiter, Amylin Makes Headway in Europe, VCs Debate Viability of Venture-Backed Biotech, & More San Diego Life Sciences News	Bruce V. Bigelow	04/21/11	San Diego
Amylin, Alkermes Shares Jump as EU Regulators Recommend Diabetes Drug	Luke Timmerman	04/15/11	San Diego
Atlas and Monsanto the Latest VC and Big Co. Getting Close	Ryan McBride	04/14/11	Boston
Hitting the Target, Missing the Mark: How Targeted Therapies Have Left Patients Wanting	Richard Watson	04/14/11	Seattle
Roche Vet Takes CEO Job at Boston’s Enlight Biosciences	Ryan McBride	04/12/11	Boston
The ImClone Alumni: Where Are They Now?	Luke Timmerman	04/07/11	New York
Xconomy’s New Frontier of Innovation: New York	Arlene Weintraub	04/05/11	New York
Tom Maniatis, Molecular Biology Pioneer, Seeks to Help Build a Kendall Square in NYC	Luke Timmerman	04/05/11	New York
Page 2 of 8	« previous page · next page »

Entry

Author

Date

Location

Bydureon FDA Deadline Set

Luke Timmerman

08/10/11

San Diego

Amylin & Takeda Halt Obesity Drug Development

Bruce V. Bigelow

08/04/11

San Diego